Dopamine-D2S receptor inhibition of calcium influx, adenylyl cyclase, and mitogen-activated protein kinase in pituitary cells: Distinct Gα and Gβγ requirements

Molecular Endocrinology

Volumn 16, Issue 10, 2002, Pages 2393-2404

  Banihashemi, Behzad ^a   Albert, Paul R ^a,b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; ADENYLATE CYCLASE; CALCIUM; CALCIUM CHANNEL L TYPE; CYCLIC AMP; DOPAMINE 2 RECEPTOR; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MUTANT PROTEIN; PERTUSSIS TOXIN; PROLACTIN; PROTEIN P44; PROTIRELIN; RAF PROTEIN;

ALPHA CHAIN; ANIMAL CELL; ARTICLE; BETA CHAIN; CALCIUM TRANSPORT; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HYPOPHYSIS CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ANIMALS; CALCIUM; CALCIUM CHANNELS; CELLS, CULTURED; FORSKOLIN; GTP-BINDING PROTEIN ALPHA SUBUNIT, GI2; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HETEROTRIMERIC GTP-BINDING PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; PERTUSSIS TOXIN; PITUITARY GLAND; PROTO-ONCOGENE PROTEINS; RATS; RECEPTORS, DOPAMINE D2; THYROTROPIN-RELEASING HORMONE;

ANIMALIA;

EID: 0036793111     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2001-0220     Document Type: Article

References (66)

1. Gether U 2000 Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev 21:90-113
2. Neer EJ 1995 Heterotrimeric G proteins: organizers of transmembrane signals. Cell 80:249-257
3. Bourne HR 1997 Pieces of the true grail: a G protein finds its target. Science 278:1898-1899
4. Yamane HK, Fung BK 1993 Covalent modifications of G-proteins. Annu Rev Pharmacol Toxicol 33:201-241
5. Gudermann T, Kalkbrenner F, Schultz G 1996 Diversity and selectivity of receptor-G protein interaction. Annu Rev Pharmacol Toxicol 36:429-459
6. Ghahremani MH, Forget C, Albert PR 2000 Distinct roles for Gα(i)2 and Gβγ, in signaling to DNA synthesis and Gα(i)3 in cellular transformation by dopamine D2S receptor activation in BALB/c 3T3 cells. Mol Cell Biol 20:1497-1506
7. Ghahremani MH, Cheng P, Lembo PM, Albert PR 1999 Distinct roles for Gαi2, Gαi3, and Gβ γ in modulation of forskolin- or Gs-mediated cAMP accumulation and calcium mobilization by dopamine D2S receptors. J Biol Chem 274:9238-9245
8. Albert PR, Robillard L 2002 G protein specificity. Traffic direction required. Cell Signal 14:407-418
9. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG 1998 Dopamine receptors: from structure to function. Physiol Rev 78:189-225
10. Albert PR 1994 Heterologous expression of G protein-linked receptors in pituitary and fibroblast cell lines. Vitam Horm 48:59-109
11. Malbon CC 1997 Heterotrimeric G-proteins and development. Biochem Pharmacol 53:1-4
12. Lajiness ME, Chio CL, Huff RM 1993 D2 dopamine receptor stimulation of mitogenesis in transfected Chinese hamster ovary cells: relationship to dopamine stimulation of tyrosine phosphorylations. J Pharmacol Exp Ther 267:1573-1581
13. Choi EY, Jeong D, Won K, Park, Baik JH 1999 G protein-mediated mitogen-activated protein kinase activation by two dopamine D2 receptors. Biochem Biophys Res Commun 256:33-40
14. Luo Y, Kokkonen GC, Wang X, Neve KA, Roth GS 1998 D2 dopamine receptors stimulate mitogenesis through pertussis toxin-sensitive G proteins and Ras-involved ERK and SAP/JNK pathways in rat C6-D2L glioma cells. J Neurochem 71:980-990
15. Albert PR, Neve KA, Bunzow JR, Civelli O 1990 Coupling of a cloned rat dopamine-D2 receptor to inhibition of adenylyl cyclase and prolactin secretion. J Biol Chem 265:2098-2104
16. Elsholtz HP, Lew AM, Albert PR, Sundmark VC 1991 Inhibitory control of prolactin and Pit-1 gene promoters by dopamine. Dual signaling pathways required for D2 receptor-regulated expression of the prolactin gene. J Biol Chem 266:22919-22925
17. Liu YF, Jakobs KH, Rasenick MM, Albert PR 1994 G protein specificity in receptor-effector coupling. Analysis of the roles of Go and Gi2 in GH4C1 pituitary cells. J Biol Chem 269:13880-13886
18. Senogles SE 1994 The D2 dopamine receptor mediates inhibition of growth in GH4ZR7 cells: involvement of protein kinase-Cε. Endocrinology 134:783-789
19. Vallar L, Muca C, Magni M, Albert P, Bunzow J, Meldolesi J, Civelli O 1990 Differential coupling of dopaminergic D2 receptors expressed in different cell types. Stimulation of phosphatidylinositol 4,5-bisphosphate hydrolysis in LtK-fibroblasts, hyperpolarization, and cytosolic-free Ca2+ concentration decrease in GH4C1 cells. J Biol Chem 265:10320-10326
20. Ohmichi M, Koike K, Nohara A, Kanda Y, Sakamoto T, Zhang ZX, Hirota K, Miyake A 1994 Dopamine inhibits TRH-induced MAP kinase activation in dispersed rat anterior pituitary cells. Biochem Biophys Res Commun 201:642-648
21. Liu YF, Ghahremani MH, Rasenick MM, Jakobs KH, Albert PR 1999 Stimulation of cAMP synthesis by Gi-coupled receptors upon ablation of distinct Gαi protein expression. Gi subtype specificity of the 5-HT1A receptor. J Biol Chem 274:16444-16450
22. Chuprun JK, Raymond JR, Blackshear PJ 1997 The heterotrimeric G protein Gαi2 mediates lysophosphatidic acid-stimulated induction of the c-fos gene in mouse fibroblasts. J Biol Chem 272:773-781
23. Koch WJ, Hawes BE, Inglese J, Luttrell LM, Lefkowitz RJ 1994 Cellular expression of the carboxyl terminus of a G protein-coupled receptor kinase attenuates G β γ-mediated signaling. J Biol Chem 269:6193-6197
24. Lembo PM, Ghahremani MH, Albert PR 1999 Receptor selectivity of the cloned opossum G protein-coupled receptor kinase 2 (GRK2) in intact opossum kidney cells: role in desensitization of endogenous α2C-adrenergic but not serotonin 1B receptors. Mol Endocrinol 13:138-147
25. 2+ concentrations to hormone secretion. Selective blockade using ionomycin and nifedipine. J Biol Chem 259:15350-15363
26. Ohmichi M, Sawada T, Kanda Y, Koike K, Hirota K, Miyake A, Saltiel AR 1994 Thyrotropin-releasing hormone stimulates MAP kinase activity in GH3 cells by divergent pathways. Evidence of a role for early tyrosine phosphorylation. J Biol Chem 269:3783-3788
27. Kanasaki H, Fukunaga K, Takahashi K, Miyazaki K, Miyamoto E 1999 Mitogen-activated protein kinase activation by stimulation with thyrotropin-releasing hormone in rat pituitary GH3 cells. Biol Reprod 61:319-325
28. Wang YH, Maurer RA 1999 A role for the mitogen-activated protein kinase in mediating the ability of thyrotropin-releasing hormone to stimulate the prolactin promoter. Mol Endocrinol 13:1094-1104
29. Albert PR, Ghahremani MH, Morris SJ 1997 Mechanisms of dopaminergic regulation of prolactin secretion. In: Neve KA, Neve RL, eds. The dopamine receptors. Totowa, NJ: Humana Press, Inc.; 359-381
30. Pawlikowski M, Kunert-Radek J, Stepien H 1978 Direct antiproliferative effect of dopamine agonists on the anterior pituitary gland in organ culture. J Endocrinol 79:245-246
31. Colao A, Merola B, Sarnacchiaro F, Di Sarno A, Landi ML, Marzullo P, Cerbone G, Ferone D, Lombardi G 1995 Comparison among different dopamine-agonists of new formulation in the clinical management of macroprolactinomas. Horm Res 44:222-228
32. Kanasaki H, Fukunaga K, Takahashi K, Miyazaki K, Miyamoto E 2000 Involvement of p38 mitogen-activated protein kinase activation in bromocriptine-induced apoptosis in rat pituitary GH3 cells. Biol Reprod 62:1486-1494
33. Saiardi A, Bozzi Y, Baik JH, Borrelli E 1997 Antiproliferative role of dopamine: loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia. Neuron 19:115-126
34. Kelly MA, Rubinstein M, Asa SL, Zhang G, Saez C, Bunzow JR, Allen RG, Hnasko R, Ben-Jonathan N, Grandy DK, Low MJ 1997 Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron 19:103-113
35. Asa SL, Kelly MA, Grandy DK, Low MJ 1999 Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice. Endocrinology 140:5348-5355
36. Bosse R, Fumagalli F, Jaber M, Giros B, Gainetdinov RR, Wetsel WC, Missale C, Caron MG 1997 Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter. Neuron 19:127-138
37. Florio T, Pan MG, Newman B, Hershberger RE, Civelli O, Stork PJ 1992 Dopaminergic inhibition of DNA synthesis in pituitary tumor cells is associated with phosphotyrosine phosphatase activity. J Biol Chem 267:24169-24172
38. Clapham DE, Neer EJ 1997 G protein β γ subunits. Annu Rev Pharmacol Toxicol 37:167-203
39. Malek D, Munch G, Palm D 1993 Two sites in the third inner loop of the dopamine D2 receptor are involved in functional G protein-mediated coupling to adenylate cyclase. FEBS Lett 325:215-219
40. Le Pechon-Vallee C, Magalon K, Rasolonjanahary R, Enjalbert A, Gerard C 2000 Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptides stimulate mitogen-activated protein kinase in the pituitary cell line GH4C1 by a 3′,5′-cyclic adenosine monophosphate pathway. Neuroendocrinology 72:46-56
41. Kievit P, Lauten JD, Maurer RA 2001 Analysis of the role of the mitogen-activated protein kinase in mediating cyclic-adenosine 3′,5′-monophosphate effects on prolactin promoter activity. Mol Endocrinol 15:614-624
42. Seabrook GR, Knowles M, Brown N, Myers J, Sinclair H, Patel S, Freedman SB, McAllister G 1994 Pharmacology of high-threshold calcium currents in GH4C1 pituitary cells and their regulation by activation of human D2 and D4 dopamine receptors. Br J Pharmacol 112:728-734
43. Lledo PM, Legendre P, Israel JM, Vincent JD 1990 Dopamine inhibits two characterized voltage-dependent calcium currents in identified rat lactotroph cells. Endocrinology 127:990-1001
44. Albert PR 2002 G protein preferences for dopamine D2 inhibition of prolactin secretion and DNA synthesis in GH4 pituitary cells. Mol Endocrinol 16:1903-1911
45. 2+ channels by G-protein β γ subunits. Nature 380:258-262
46. Zamponi GW, Snutch TP 1998 Modulation of voltage-dependent calcium channels by G proteins. Curr Opin Neurobiol 8:351-356
47. Bell DC, Butcher AJ, Berrow NS, Page KM, Brust PF, Nesterova A, Stauderman KA, Seabrook GR, Nurnberg B, Dolphin AC 2001 Biophysical properties, pharmacology, and modulation of human, neuronal L-type (α(1D), Ca(V)1.3) voltage-dependent calcium currents. J Neurophysiol 85:816-827
48. Safa P, Boulter J, Hales TG 2001 Functional properties of Cav1.3 (α1D) L-type Ca2+ channel splice variants expressed by rat brain and neuroendocrine GH3 cells. J Biol Chem 276:38727-38737
49. Gutkind JS 1998 Cell growth control by G protein-coupled receptors: from signal transduction to signal integration. Oncogene 17:1331-1342
50. van Biesen T, Luttrell LM, Hawes BE, Lefkowitz RJ 1996 Mitogenic signaling via G protein-coupled receptors. Endocr Rev 17:698-714
51. Schwindinger WF, Robishaw JD 2001 Heterotrimeric G-protein βγ,-dimers in growth and differentiation. Oncogene 20:1653-1660
52. Vossler MR, Yao H, York RD, Pan MG, Rim CS, Stork PJ 1997 cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell 89:73-82
53. Gudermann T, Grosse R, Schultz G 2000 Contribution of receptor/G protein signaling to cell growth and transformation. Naunyn Schmiedebergs Arch Pharmacol 361:345-362
54. Wang YH, Jue SF, Maurer RA 2000 Thyrotropin-releasing hormone stimulates phosphorylation of the epidermal growth factor receptor in GH3 pituitary cells. Mol Endocrinol 14:1328-1337
55. Smith J, Yu R, Hinkle PM 2001 Activation of MAPK by TRH requires clathrin-dependent endocytosis and PKC but not receptor interaction with β-arrestin of receptor endocytosis. Mol Endocrinol 15:1539-1548
56. 2+-dependent effect of D2 dopaminergic receptor activation in rat lactotroph cells. J Biol Chem 263:10127-10134
57. Albert PR 2002 Editorial: dopamine-D2-mediated inhibition of TRH-Induced PLC activation in pituitary cells-director indirect? Endocrinology 143:744-746
58. Dhillon AS, Meikle S, Yazici Z, Eulitz M, Kolch W 2002 Regulation of Raf-1 activation and signalling by dephosphorylation. EMBO J 21:64-71
59. Conrad KE, Oberwetter JM, Vaillancourt R, Johnson GL, Gutierrez-Hartmann A 1994 Identification of the functional components of the Ras signaling pathway regulating pituitary cell-specific gene expression. Mol Cell Biol 14:1553-1565
60. Tian J, Ma HW, Bancroft C 1995 Constitutively active Gq-α stimulates prolactin promoter activity via a pathway involving Raf activity. Mol Cell Endocrinol 112:249-256
61. Dent P, Wang Y, Gu YZ, Wood SL, Reardon DB, Mangues R, Pellicer A, Schonbrunn A, Sturgill TW 1997 S49 cells endogenously express subtype 2 somatostatin receptors which couple to increase protein tyrosine phosphatase activity in membranes and down-regulate Raf-1 activity in situ. Cell Signal 9:539-549
62. Florio T, Arena S, Thellung S, Iuliano R, Corsaro A, Massa A, Pattarozzi A, Bajetto A, Trapasso F, Fusco A, Schettini G 2001 The activation of the phosphotyrosine phosphatase η (r-PTP η) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation. Mol Endocrinol 15:1838-1852
63. Lopez F, Esteve JP, Buscail L, Delesque N, Saint-Laurent N, Theveniau M, Nahmias C, Vaysse N, Susini C 1997 The tyrosine phosphatase SHP-1 associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signaling. J Biol Chem 272:24448-24454
64. Keilhack H, Tenev T, Nyakatura E, Godovac-Zimmermann J, Nielsen L, Seedorf K, Bohmer FD 1998 phosphotyrosine 1173 mediates binding of the protein-tyrosine phosphatase SHP-1 to the epidermal growth factor receptor and attenuation of receptor signaling. J Biol Chem 273:24839-24846
65. Jordan JD, Carey KD, Stork PJ, Iyengar R 1999 Modulation of rap activity by direct interaction of Gα(o) with Rap1 GTPase-activating protein. J Biol Chem 274:21507-21510
66. Grewal SS, Fass DM, Yao H, Ellig CL, Goodman RH, Stork PJ 2000 Calcium and cAMP signals differentially regulate cAMP-responsive element-binding protein function via a Rap1-extracellular signal-regulated kinase pathway. J Biol Chem 275:34433-34441